Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script
Frontiers in Bioscience-Landmark · 21.05.2026 · 31 (5)
DOI: 10.31083/fbl52945 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 21.05.2026. Verfasst von Ralf Weiskirchen. Beteiligte Einrichtung: Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aache…. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.
Zitieren
APA
Weiskirchen, R. (2026). Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark, 31(5). https://doi.org/10.31083/fbl52945
Vancouver
Weiskirchen R. Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark. 2026;31(5). doi:10.31083/fbl52945
BibTeX
@article{Weiskirchen2026,
author = {Weiskirchen, Ralf},
title = {Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {5},
doi = {10.31083/fbl52945}
}
EUVIMED